Delivery Order SPE2DB22D2006-SPE2DB24FW2TV
Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $4,721.08 firm fixed-price delivery order contract for the supply of 4,565,285,732 units of Xarelto 20 mg tablets. The contract has an ultimate completion date of July 30, 2024. Amerisourcebergen is the prime contractor, and the contract is not set aside. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,879.18 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,563,280,716 units of the drug Xarelto 20 mg tablets. The contract has an ultimate completion date of January 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical division, valued at $999,999,999 and running through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $56,409.59 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565551169 - Xarelto 20 mg Tablets. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
- This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $18,652.35 for the supply of Xarelto 20 mg tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of September 13, 2024. The contract is a Firm Fixed Price type without any set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
- The U.S. Defense Logistics Agency (DLA) awarded a $14,019.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division to supply XARELTO 20 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of critical pharmaceutical and medical supplies. As a major pharmaceutical distributor,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation. The $31,355.64 contract is for the supply of Xarelto 20 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary...
- This federal contract award, valued at $6,795.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Xarelto 20 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of January 18, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,510.57 firm fixed-price delivery order is for the supply of Xarelto 20 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is a delivery order valued at $43,156.71, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Xarelto 20 mg tablets, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,235.02 delivery order contract is for the supply of the pharmaceutical product Xarelto 20 mg tablets. The contract has a firm fixed price structure and an ultimate completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FW2TVDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $19,892.16 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xarelto 20 mg tablets, a prescription medication, to support military treatment facilities and other government healthcare programs. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to the government. This specific contract award is not designated as a set-aside.
Generated 11/7/24, 9:27 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.9k | 8/8/24 |